A phase II trial of pembrolizumab combined with cisplatin-based chemotherapy as first-line systemic therapy in advanced penile cancer
Type of Study: Clinical Trial
Sponsor / Support: LACOG
Primary Objectives: The primary objective is to evaluate if pembrolizumab improves Overall Response Rate in first-line setting associated with platinum-based chemotherapy.
Design: This is a phase II, multicenter, open-label, one-arm interventional trial.
Sample Size: 33 patients
Principal Investigator: Fernando Cotait Maluf
Countries LATAM: Brazil
LACOG 1518 – Bladder Cancer Registry
LACOG 0515 – Testicular Registry
LACOG 0217 – IRONMAN
LACOG 1818 – Prostate Cancer Registry
LACOG 0218 – Hercules
LACOG 0415 – APA in Prostate Cancer
LACOG 0519 – PEACE III